Frontiers in Oncology | Breast Cancer

Original Research

Accepted on 23 Apr 2025

Personalized Prediction of Breast Cancer Candidates for Anti-HER2 Therapy Using 18 F-FDG PET/CT Parameters and Machine Learning: A Dual-Center Study

in Breast Cancer

Zhenguo Sun
Jianxiong Gao
Yu Wenji
Xiaoshuai Yuan
Peng Du
Peng Chen
Yuetao Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1590769

Case Report

Published on 22 Apr 2025

Solid subtype of adenoid cystic carcinoma of the breast with multiple distant metastases: a case report and literature review

in Breast Cancer

Yibo Zhang
Xidie Li
Yaxi Xue
Xiaohui Huang
Fengxian An
Miduo Tan

Frontiers in Oncology

doi 10.3389/fonc.2025.1565175

205 views

Opinion

Accepted on 21 Apr 2025

Breaking the Dichotomy of HER2: Highlighting the Flaws of Simplifying Variables

in Breast Cancer

Jacob Jerome Pozin
Reid Shaw
Jennifer Weiss

Frontiers in Oncology

doi 10.3389/fonc.2025.1494417

Original Research

Accepted on 17 Apr 2025

Clinical Value of Quantitative Analysis of Sonazoid-Contrast Enhanced Ultrasound Combined with Shear Wave Elastography in Discriminating and Diagnosing Breast Tumor Characteristics

in Breast Cancer

Gang Wang
Jicheng Zhang
Bin Tu
Fen Huang
Litao Ruan

Frontiers in Oncology

doi 10.3389/fonc.2025.1485671

107 views

Original Research

Accepted on 17 Apr 2025

Ferroptosis-related gene signature-based subtype identification of triplenegative breast cancer to prioritize treatment strategies

in Breast Cancer

Yongzhen Chen
Xiaoying Huang
Junqi Wang
Hu Chao
Zheng Yanan
Yumeng Wang
Shuqian Zheng
Guozhong Ji
Qiang You

Frontiers in Oncology

doi 10.3389/fonc.2025.1541119

123 views

Original Research

Accepted on 17 Apr 2025

Machine learning-based ultrasound radiomics for predicting risk of recurrence in breast cancer

in Breast Cancer

Wei Fan
Hao Cui
Xiaoxue Liu
Xudong Zhang
Xinran Fang
Junjia Wang
Zihao Qin
Xiuhua Yang
Jiawei Tian
Lei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1542643

129 views

Systematic Review

Accepted on 16 Apr 2025

Acupuncture for Systemic therapy-associated Insomnia in Patients with Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials

in Breast Cancer

Lingling Gao
Ying Sun
Tianyu Luo
Huiying Chen
Shan Huang
Ling Zhu
Meixia Ye

Frontiers in Oncology

doi 10.3389/fonc.2025.1494929

118 views

Review

Accepted on 16 Apr 2025

The interplay between the immune response and neoadjuvant therapy in breast cancer

in Breast Cancer

Noémie Thomas
Theodoros Foukakis
Karen Willard-Gallo

Frontiers in Oncology

doi 10.3389/fonc.2025.1469982

Original Research

Published on 16 Apr 2025

A nomogram for predicting subsequent liver metastasis in patients with metastatic breast cancer

in Breast Cancer

Xuanchen Liu
Weipeng Zhao
Yongsheng Jia
Li Zhang
Zhongsheng Tong

Frontiers in Oncology

doi 10.3389/fonc.2025.1417858

355 views

Original Research

Published on 16 Apr 2025

Intratumoral and peritumoral radiomics based on automated breast volume scanner for predicting human epidermal growth factor receptor 2 status

in Breast Cancer

Hao Zhang
Qing Miao
Yan Fu
Ruike Pan
Qing Jin
Changjiang Gu
Xuejun Ni

Frontiers in Oncology

doi 10.3389/fonc.2025.1556317

310 views

Original Research

Published on 16 Apr 2025

Additional prognostic value of the BCT score in ER+HER2- breast cancer patients receiving a 21-gene assay-guided adjuvant treatments

in Breast Cancer

Sung Gwe Ahn
Jonghan Yu
Seung Ho Baek
Yeon Jin Kim
Woo Young Kim
Jai Hyun Chung
Soong June Bae
Seok Won Kim
Seok Jin Nam
Gyungyub Gong

Frontiers in Oncology

doi 10.3389/fonc.2025.1517073

540 views

Original Research

Published on 16 Apr 2025

The therapeutic effect of acupuncture in the treatment of chemotherapy-induced peripheral neuropathy: a randomized controlled trial

in Breast Cancer

Jinqun Xu
Qing Zhang
Na Xue
Cui Zhang
Weiru Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1500410

224 views

Original Research

Accepted on 15 Apr 2025

Chemotherapy as a Critical Treatment Modality for Non-Surgical Metaplastic Breast Cancer: Evidence from SEER Database and Clinical Cohort

in Breast Cancer

Pin Wang
Ying Liu
Li Ling
Jian Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1534204

109 views

Original Research

Published on 15 Apr 2025

Cost-effectiveness of companion BRCA testing and adjuvant olaparib treatment in patients with BRCA-mutated high-risk HER2-negative early breast cancer

in Breast Cancer

Silviya Nikolova
Wenkang Ma
Gurdeep S. Sagoo
Yogesh Punekar
Elizabeth Sheppard

Frontiers in Oncology

doi 10.3389/fonc.2025.1419071

383 views

Original Research

Accepted on 14 Apr 2025

Real-world treatment patterns and outcomes among patients with HER2-positive unresectable or metastatic breast cancer in China

in Breast Cancer

Jiajia Huang
Limin Chen
Lihua Song
Zhongsheng Tong
Tao Sun
Xiaojia Wang
Yi Liu
Shusen Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1527990

119 views

Original Research

Accepted on 14 Apr 2025

The m6A reader YTHDF3 promotes TNBC progression by regulating CENPI stabilization

in Breast Cancer

Yulu Zhang
Shunji Chen
Qiaosheng Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1546723